Sentencing Commission hears widespread support to de-emphasize drug weight, add low-level function relief

WASHINGTON — The U.S. Sentencing Commission on Oct. 12 heard extensive testimony urging changes to the federal drug guidelines that would reduce reliance on quantity and purity as the chief measure of culpability and add clearer relief for low-level participants.

Advocates across the courtroom — including federal defenders, prosecutors, members of the Commission's advisory panels and academics — told commissioners that the current framework, which ties guideline ranges tightly to drug type and weight under U.S.S.G. —2D1.1, produces overly long sentences for many people who serve limited roles in distribution networks. Many witnesses backed lowering the guideline's highest base offense level to a figure in the low 30s (several urged level 30) and adopting a specific-offense-characteristic that reduces sentences for primary low-level functions.

Why it matters: Sentencing that hinges primarily on weight and purity can yield large prison terms for couriers, stash-house workers and other participants who did not make managerial decisions or reap sizable profits. Panelists said reforms would better align punishment with moral culpability and current judicial practice, reduce racial disparity, and free resources for enforcement against truly high-level…